Ebola Vaccine - low dose
rVSV-EBOV-01
Phase 1 mab completed
Quick answer
Ebola Vaccine - low dose for Ebola Virus Disease is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Ebola Virus Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed